Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue
Submit an article Journal homepage
151
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Social Return On Investment For Patient Treated By Continuous Ambulatory Peritoneal Dialysis: A Case Study In Ubon Ratchathani Province, Thailand

Pattama Lophongpanit1 Health Science Program, Faculty of Medicine, Mahasarakham University, Talat Subdistrict, Mueang, Maha Sarakham Province 44000, ThailandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5854-9280
ORCID Icon,
Sirinart Tongsiri2 Faculty of Medicine, Mahasarakham University, Talat Subdistrict, Mueang, Maha Sarakham Province 44000, Thailand
&
Nalinee Thongprasert3 Faculty of Business Administration and Management, Ubon Ratchathani Rajabhat University, Mueang, Ubon Ratchathani Province 34000, ThailandORCID Iconhttps://orcid.org/0000-0002-1571-2890
ORCID Icon
Pages 569-578 | Published online: 23 Sep 2019

References

  • Thawornchaisit P, De Looze F, Reid CM, et al. Health-risk factors and the prevalence of chronic kidney disease: cross-sectional findings from a national cohort of 87,143 Thai Open University students. Glob J Health Sci. 2015;7(5):59–72. doi:10.5539/gjhs.v7n5p5926156905
  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-023245604
  • Vejakama P, Ingsathit A, Attia J, Thakkinstian A. Epidemiological study of chronic kidney disease progression: a large-scale population-based cohort study. Medicine (Baltimore). 2015;94(4):e475. doi:10.1097/MD.000000000000047525634196
  • Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet (London, England). 2015;385(9981):1975–1982. doi:10.1016/S0140-6736(14)61601-9
  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.015876527383068
  • Prakongsai P, Palmer N, Uay-Trakul P, Tangcharoensathien V, Mills A. The implications of benefit package design: the impact on poor Thai households of excluding renal replacement therapy. J Int Dev. 2009;21(2):291–308. doi:10.1002/jid.1553
  • Tantivess S, Werayingyong P, Chuengsaman P, Teerawattananon Y. Universal coverage of renal dialysis in Thailand: promise, progress, and prospects. BMJ. 2013;346:f462. doi:10.1136/bmj.f46223369775
  • Cheawchanwattana A, Limwattananon C, Limwattananon S, Tangcharoensathien V, Sirivong T, Pongskul C. Cost utility analysis of hemodialysis and continuous ambulatory peritoneal dialysis in patients with end stage renal disease in Thailand. J Nephrol Soc Thail. 2003;9(2):158–169.
  • Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health. 2007;10(1):61–72. doi:10.1111/j.1524-4733.2006.00145.x17261117
  • The Nephrology Society of Thailand. Thailand renal replacement therapy year 2015. Bangkok: The Nephrology Society of Thailand; 2016. Available from: http://www.nephrothai.org/images/Final_TRT_report_2015_ฉบบแก้ไข.pdf. Accessed August 25, 2019.
  • Changsirikulchai S, Sriprach S, Thokanit NS, Janma J, Chuengsaman P, Sirivongs D. Survival analysis and associated factors in thai patients on peritoneal dialysis under the PD-first policy. Perit Dial Int. 2018;38(3):172–178. doi:10.3747/pdi.2017.0012729437140
  • Pongskul C, Sirivongs D, Keobounma T, Chanlertrith D, Promajuk P, Limwatananon C. Survival and Technical Failure in a Large Cohort of Thai CAPD Patients. Vol. 89; 2006 http://www.medassocthai.org/journal. Accessed 823, 2019.
  • Rattanachotphanit T, Waleekhachonloet O, Chanasopon S, Ausornsagiam W, Kanjanasilp J, Suwattanasilp A. Quality of life and utilities of end stage renal disease patients undergoing dialysis. Isan J Pharm Sci. 2018;14(4):88–98.
  • Maddocks J Measuring and reporting on social value. 2015 Available from: http://www.charitysorp.org/media/642564/cipfa-draft-discussion-paper-social-value-july-2015.pdf. Accessed 102, 2018.
  • Eurodiaconia. Measuring social value. 2016 Available from: http://www.cmsimpact.org/wp-content/uploads/2016/01/Eurodiaconia-Measuring-Social-Value.pdf. Accessed 101, 2018.
  • Hamelmann C, Turatto F, Then V, Dyakova M. Social Return on Investment: Accounting for Value in the Context of Implementing Health 2020 and the 2030 Agenda for Sustainable Development. Copenhagen; 2017 Available from: http://www.euro.who.int/__data/assets/pdf_file/0009/347976/20170828-h0930-SROI-report-final-web.pdf?ua=1. Accessed 102, 2018.
  • The SROI Network Accounting for Value. A guide to social return on investment. 2012 Available from: http://www.socialvalueuk.org/app/uploads/2016/03/TheGuidetoSocialReturnonInvestment2015.pdf. Accessed 101, 2018.
  • Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ. The use of triangulation in qualitative research. Oncol Nurs Forum. 2014;41(5):545–547. doi:10.1188/14.ONF.545-54725158659
  • Muyambi K, Gurd B, Martinez L, et al. Issues in using social return on investment as an evaluation tool. Eval J Australas. 2017;17(3):32–39. doi:10.1177/1035719X1701700305
  • Chandoevwit W, Thampanishvong K, Rojjananukulpong R. Social return on investment: health promotion programs. TDRI Q Rev. 2014;29(2):4–12.
  • Watson KJ, Whitley T. Applying Social Return on Investment (SROI) to the built environment. Build Res Inf. 2017;45(8):875–891. doi:10.1080/09613218.2016.1223486

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.